Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200366946> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4200366946 endingPage "5976" @default.
- W4200366946 startingPage "5958" @default.
- W4200366946 abstract "To systematically evaluate the clinical efficacy of 14 oral Chinese patent medicines combined with Azithromycin in the treatment of mycoplasma pneumonia in children with network Meta-analysis. Computer retrieval was performed for such databases as CNKI, VIP, Wanfang, CBM, PubMed, EMbase and Cochrane Library to screen out randomized controlled trials of oral Chinese patent medicines combined with Azithromycin in the treatment of mycoplasma pneumonia in children from the time of database establishment to September 2020. The included studies were evaluated by the Cochrane Risk Assessment tool. Stata 14.0 and Review Manager 5.3 software were used for data statistical analysis. A total of 60 RCTs were included in this study, involving 14 oral Chinese patent medicines. The efficacy ranking based on network Meta-analysis was as follows:(1)in terms of total effective rate, top five Chinese patent medicines in surface under the cumulative ranking curve(SUCRA) were Xiao'er Xiaoji Zhike Oral Liquid, Xiao'er Chiqiao Qingre Granules, Xiao'er Feike Granules, Pudilan Xiaoyan Oral Liquid and Lanqin Oral Liquid;(2)in terms of antifebrile time, top five Chinese patent medicines in SUCRA were Huaiqihuang Granules, Xiao'er Magan Granules, Xiao'er Kechuanling Granules/Oral Liquid, Shuanghuang-lian Oral Liquid for children and Xiao'er Xiaoji Zhike Oral Liquid;(3)in terms of cough disappearance time, top five Chinese patent medicines in SUCRA were Xiao'er Magan Granules, Huaiqihuang Granules, Xiao'er Chiqiao Qingre Granules, Xiao'er Feire Kechuan Oral Liquid and Xiao'er Kechuanling Granules/Oral Liquid;(4)in terms of rale disappearance time, top five Chinese patent medicines in SUCRA were Xiao'er Magan Granules, Huaiqihuang Granules, Xiao'er Feire Kechuan Oral Liquid, Shuanghuanglian Oral Liquid for children and Yupingfeng Granules. The results showed that on the basis of the use of Azithromycin, combined administration with oral Chinese patent medicines could improve the overall clinical efficacy in the treatment of mycoplasma pneumonia in children. However, due to the large differences in the quality and the number of included studies among various therapeutic measures, the ranking results of SUCRA of Chinese patent medicines need to be verified by high-quality multi-center, large-sample, randomized double-blind trials in the future." @default.
- W4200366946 created "2021-12-31" @default.
- W4200366946 creator A5040223264 @default.
- W4200366946 creator A5081268801 @default.
- W4200366946 creator A5081752664 @default.
- W4200366946 creator A5083668058 @default.
- W4200366946 creator A5091188222 @default.
- W4200366946 date "2021-11-01" @default.
- W4200366946 modified "2023-09-27" @default.
- W4200366946 title "[Network Meta-analysis of 14 oral Chinese patent medicines combined with Azithromycin in treatment of mycoplasma pneumonia in children]." @default.
- W4200366946 doi "https://doi.org/10.19540/j.cnki.cjcmm.20210408.501" @default.
- W4200366946 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34951188" @default.
- W4200366946 hasPublicationYear "2021" @default.
- W4200366946 type Work @default.
- W4200366946 citedByCount "2" @default.
- W4200366946 countsByYear W42003669462022 @default.
- W4200366946 crossrefType "journal-article" @default.
- W4200366946 hasAuthorship W4200366946A5040223264 @default.
- W4200366946 hasAuthorship W4200366946A5081268801 @default.
- W4200366946 hasAuthorship W4200366946A5081752664 @default.
- W4200366946 hasAuthorship W4200366946A5083668058 @default.
- W4200366946 hasAuthorship W4200366946A5091188222 @default.
- W4200366946 hasConcept C126322002 @default.
- W4200366946 hasConcept C142724271 @default.
- W4200366946 hasConcept C188947578 @default.
- W4200366946 hasConcept C204787440 @default.
- W4200366946 hasConcept C2777914695 @default.
- W4200366946 hasConcept C2777980684 @default.
- W4200366946 hasConcept C2778907293 @default.
- W4200366946 hasConcept C2779215961 @default.
- W4200366946 hasConcept C2779706735 @default.
- W4200366946 hasConcept C501593827 @default.
- W4200366946 hasConcept C556039675 @default.
- W4200366946 hasConcept C71924100 @default.
- W4200366946 hasConcept C86803240 @default.
- W4200366946 hasConcept C89423630 @default.
- W4200366946 hasConcept C95190672 @default.
- W4200366946 hasConcept C98274493 @default.
- W4200366946 hasConceptScore W4200366946C126322002 @default.
- W4200366946 hasConceptScore W4200366946C142724271 @default.
- W4200366946 hasConceptScore W4200366946C188947578 @default.
- W4200366946 hasConceptScore W4200366946C204787440 @default.
- W4200366946 hasConceptScore W4200366946C2777914695 @default.
- W4200366946 hasConceptScore W4200366946C2777980684 @default.
- W4200366946 hasConceptScore W4200366946C2778907293 @default.
- W4200366946 hasConceptScore W4200366946C2779215961 @default.
- W4200366946 hasConceptScore W4200366946C2779706735 @default.
- W4200366946 hasConceptScore W4200366946C501593827 @default.
- W4200366946 hasConceptScore W4200366946C556039675 @default.
- W4200366946 hasConceptScore W4200366946C71924100 @default.
- W4200366946 hasConceptScore W4200366946C86803240 @default.
- W4200366946 hasConceptScore W4200366946C89423630 @default.
- W4200366946 hasConceptScore W4200366946C95190672 @default.
- W4200366946 hasConceptScore W4200366946C98274493 @default.
- W4200366946 hasIssue "22" @default.
- W4200366946 hasLocation W42003669461 @default.
- W4200366946 hasOpenAccess W4200366946 @default.
- W4200366946 hasPrimaryLocation W42003669461 @default.
- W4200366946 hasRelatedWork W13454653 @default.
- W4200366946 hasRelatedWork W14857518 @default.
- W4200366946 hasRelatedWork W14921521 @default.
- W4200366946 hasRelatedWork W16877573 @default.
- W4200366946 hasRelatedWork W19222313 @default.
- W4200366946 hasRelatedWork W19388120 @default.
- W4200366946 hasRelatedWork W20088784 @default.
- W4200366946 hasRelatedWork W8234527 @default.
- W4200366946 hasRelatedWork W8369838 @default.
- W4200366946 hasRelatedWork W9595520 @default.
- W4200366946 hasVolume "46" @default.
- W4200366946 isParatext "false" @default.
- W4200366946 isRetracted "false" @default.
- W4200366946 workType "article" @default.